In addition to its well-established role in angiogenesis in contexts of embryonic development and brain tumors, recent experiments have demonstrated that VEGFR1's ligand, VEGF, also has effects on neurons and glia that are relevant to neurological disorders (Carmeliet and Storkebaum, 2002). Here, FLT1 is linked to nervous system disorder.